Self-Driving Lab for Rapid Therapeutic Experimentation

Today, the discovery of each new therapeutic takes years and millions of dollars. Much of that time and money is spent on refining the particular composition of the drug, optimizing it for its intended application. It’s a critical part of the process, but one that time constrains.

Oceanit’s Self-Driving Lab can explore new therapeutics orders of magnitude faster, automating the act of discovery and formulation optimization. Like an efficient self-driving car, a technician can plot an outcome, set parameters, and let the machine calculate the optimal path. Wrong turn? No problem. Algorithmic decision-making will look for a better route.

When combined with the exciting new technology like organoids, the Self-Driving lab has another key advantage — it can personalize medicine to an individual, performing large numbers of high-fidelity experiments that exceed animal testing in quality of results. And it can be executed at speed and scale. Organoids are tissue cultures that mimic the structure and function of a full-scale organ, using actual human cells. This gives us the ability to tailor a drug to a particular person’s genetic makeup — opening up the field of low-cost, ultra-personalized medicine, delivered at scale.